Moscow plans to send the Mir space station to its end over the Pacific Ocean, prompting concerns that errant station chunks could threaten nearby nations such as Japan or Australia. The 135-ton ...
U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Queen Latifah recently showcased a notable weight loss during a Disneyland outing with longtime partner Eboni Nichols.
Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...
U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 14.3% in the afternoon session after the U.S. Food and ...
Queen Latifah showed off her dramatic weight lossduring a fun-filled day at Disneyland with longtime partner Eboni Nichols.
A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...
After Madison LeCroy gave birth to daughter Teddi in June, it took some time for her to feel like herself, which is why she decided to go on a weight-loss journey. "After having my second child, I had ...
WW International is launching a platform that integrates its wellness program with GLP-1 drugs. Should you buy the stock now?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results